quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

Dow confirms correction as traders worry about war

View original at sg.finance.yahoo.com
Dow confirms correction as traders worry about war By Noel Randewich March 27 (Reuters) - The Dow Jones Industrial Average fell 1.7% on Friday as investors worried about the global economic ‌impact of the war in Iran, leaving the blue-chip index down ‌10% from its record high close on February 10 and confirming it has…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Investors are weighing whether the downturn is a temporary dip similar to the recovery that followed the 2025 selloff, or the start of a sustained period of risk tied to the war

    60% confidence
  • The Dow Jones Industrial Average has confirmed it has been in a correction since its record high close on February 10, now down 10% from that level

    60% confidence
  • Sky-high oil prices have sparked fears of inflation, with traders expecting the Federal Reserve to be more likely to raise interest rates by year-end than cut rates

    60% confidence

Data points we hold from this source

Dow Jones Industrial Average · drawdown from peak-10 percent
Dow Jones Industrial Average · decline since iran war-7 percent
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Dow confirms correction as traders worry about war — Source | Via News | pt.VIA.NEWS